Paramount Bed Holdings Co (TSE:7817) EBIT: 円3,376 Mil (TTM As of Sep. 2025)


TSE:7817 Paramount Bed Holdings Co Ltd TSE:7817
69 GF Score
Price 円3,515.00
GF Value 円2,907.43
! 6 Warning Signs
View Full Analysis

What is Paramount Bed Holdings Co EBIT?

Paramount Bed Holdings Co TSE:7817 +0.14% 69 EBIT is 円3,376 Mil as of Sep. 2025. GuruFocus rates TSE:7817 with a GF Score™ of 69/100 and a GF Value™ of 円2,907.43. The stock has 6 warning signs investors should review.

Paramount Bed Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2025 was 円2,070 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was 円3,376 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Paramount Bed Holdings Co's annualized ROC % for the quarter that ended in Sep. 2025 was 3.24%. Paramount Bed Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 11.20%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Paramount Bed Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 2.53%.

Paramount Bed Holdings Co  (TSE:7817) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Paramount Bed Holdings Co's annualized ROC % for the quarter that ended in Sep. 2025 is calculated as:

ROC % (Q: Sep. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Sep. 2025 ))/ count )
=6268 * ( 1 - 36.29% )/( (122140 + 124697)/ 2 )
=3993.3428/123418.5
=3.24 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=176022 - 11564 - ( 42318 - max(0, 20762 - 86953+42318))
=122140

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=180863 - 12964 - ( 43202 - max(0, 23009 - 88563+43202))
=124697

Note: The Operating Income data used here is four times the quarterly (Sep. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Paramount Bed Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Sep. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=8280/( ( (49168 + max(25399, 0)) + (49288 + max(23942, 0)) )/ 2 )
=8280/( ( 74567 + 73230 )/ 2 )
=8280/73898.5
=11.20 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(21689 + 12678 + 10268) - (11564 + 0 + 7672)
=25399

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22086 + 12959 + 10316) - (12964 + 0 + 8455)
=23942

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Paramount Bed Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2025 )
=3376/133308.385
=2.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paramount Bed Holdings Co EBIT Related Terms

Paramount Bed Holdings Co EBIT Historical Data

* Premium members only.

The historical data trend for Paramount Bed Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paramount Bed Holdings Co EBIT Chart

Paramount Bed Holdings Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,939.00 13,526.00 13,906.00 15,618.00 12,998.00

Paramount Bed Holdings Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,218.00 909.00 0.00 1,306.00 2,070.00

TSE:7817 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paramount Bed Holdings Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Paramount Bed Holdings Co's EV-to-EBIT falls into.


TSE:7817
69GF Score
Paramount Bed Holdings Co Ltd TSE:7817
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paramount Bed Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,376 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円3,376 Mil mean?
Paramount Bed Holdings Co (TSE:7817) has a EBIT of 円3,376 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Paramount Bed Holdings Co.
Is Paramount Bed Holdings Co's EBIT too high?
Paramount Bed Holdings Co's current EBIT is 円3,376 Mil. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's EBIT compare to ISRG and BDX?
Paramount Bed Holdings Co's EBIT of 円3,376 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Paramount Bed Holdings Co. Paramount Bed Holdings Co's current EBIT is 円3,376 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current EBIT of 円3,376 Mil. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current EBIT is 円3,376 Mil. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current EBIT is 円3,376 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?

Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued. The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.

Key valuation signals for TSE:7817:

  • EBIT: 円3,376 Mil
  • GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paramount Bed Holdings Co Business Description

Address 14-5, Higashisuna, 2-chome, Koto-ku, Tokyo, JPN, 136-8671
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score

Get the complete analysis for TSE:7817

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,515.00
Price
円2,907.43
GF Value